ADRD

Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias

The purpose of this study was to determine differences in health care utilization, care satisfaction, and health status for Medicare Advantage (MA) and Traditional Medicare (TM) beneficiaries with and without Alzheimer’s Disease and Related Dementias (ADRD). A cohort study was conducted of MA and TM beneficiaries with and without ADRD from all publicly available years of the Medicare Current Beneficiary Survey between 2010 and 2016. To address advantageous selection into MA plans, county-level MA enrollment rate was used as an instrument. Data were analyzed between July 2019 and December 2019. Compared with TM beneficiaries, MA beneficiaries had lower health care utilization without compromising care satisfaction and health status. This difference was more pronounced among beneficiaries with ADRD. These findings suggest that MA plans may be delivering health care more efficiently than TM, especially for beneficiaries with ADRD.

Park S, White L, Fishman P, Larson EB, Coe NB: Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias. JAMA Network Open 3(3), Mar 2020.

Cost of Dementia in Medicare Managed Care: A Systematic Literature Review

In this article, the authors conducted a systematic review of studies reporting the direct healthcare costs of treating older adults with diagnosed Alzheimer disease and related dementias (ADRD) within private Medicare managed care plans. 

P Fishman, NB Coe, L White, S Park, B Ingraham, EB Larson. “Cost of Dementia in Managed Care:  A Systematic Literature Review” American Journal of Managed Care.  2019. August. 

Medicare expenditures attributable to dementia

This article estimates dementia's incremental cost to the traditional Medicare program. The authors compared Medicare expenditures for 60 months following a claims-based dementia diagnosis to those for a randomly selected, matched comparison group.   Dementia's five-year incremental cost to the traditional Medicare program is approximately $15 700 per patient, nearly half of which is incurred in the first year after diagnosis. Increased costs for individuals with dementia were driven by more intensive use of Medicare part A covered services.

White, L, P Fishman, A Basu, EB Larson, NB Coe, “Medicare Expenditures Attributable to Dementia.” Health Services Research. 2019. P 1-9

The Effect of Retirement on Cognitive Functioning

Coe, NB, HM von Gaudecker, M Lindeboom, and J Maurer.  “The Effect of Retirement on Cognitive Functioning.”  Health Economics 2012; 21(8):913-927.

Gender of Study Partners and Research Participants Associated with Differences in Study Partner Ratings of Cognition and Activity Level

Studies of Alzheimer's disease typically include "study partners" (SPs) who report on participants' cognition and function. Prior studies show SP reports differ depending on the relationship between the SP and participant, that is, spouse or adult child. Adult children SPs are typically female. Could differing reports be due to gender? Knowing this may help explain variability in measurement.

Stites, S. D., Gurian, A., Coykendall, C., Largent, E. A., Harkins, K., Karlawish, J., & Coe, N. B. (2023). Gender of Study Partners and Research Participants Associated With Differences in Study Partner Ratings of Cognition and Activity Level. The journals of gerontology. Series B, Psychological sciences and social sciences78(8), 1318–1329. https://doi.org/10.1093/geronb/gbad026